Kromek grows underlying product sales but reports lower annual earnings
Kromek ($KMK) reported annual revenue of £27.1 million, up from £26.5 million, while adjusted EBITDA fell to £8.1 million from £10.3 million. Pre-tax profit declined to £2.5 million from £3.1 million. Gross margin dropped to 62.8% from 80.9%, reflecting a less favorable mix after unusually high licensing income in the comparison period. Underlying advanced-imaging revenue increased 76% to £6.7 million, excluding licensing and one-off items, while chemical, biological, radiological and nuclear de
0